3 January 2020
AiRISTA Flow Named in Gartner Hype Cycle for Healthcare Providers as a Healthcare Real-Time Location System Sample Vendor
SPARKS, MD. DECEMBER 18, 2019
AiRISTA Flow has been named a Sample Vendor of Healthcare Real-Time Location Systems (RTLS) in Gartner’s Hype Cycle for Healthcare Providers, 2019. The company is listed among few other RTLS technology providers in a report that shares information for today’s healthcare professionals on the industry’s evolving technology scene. AiRISTA Flow was also recognized in the Gartner Magic Quadrant for Indoor Location Services, Global for 2019.
Gartner’s Hype Cycle for Healthcare Providers is more than seventy pages of data on existing and emerging information technology solutions serving the healthcare industry. Gartner Hype Cycles provide a graphic representation of the maturity and adoption of technologies and applications, and how they are potentially relevant to solving real business problems and exploiting new opportunities. Each category profile gives a definition of the technology’s modern use in the market and includes information on its position and adoption speed justification, business impact, benefit ranking, market penetration, and maturity, in addition to listing Sample Vendors and recommended reading.
The yearly report’s insights help healthcare providers conduct more strategic planning efforts as they leverage its data to assess their own IT application, system, and analytics needs and consider technology’s role in improving health outcomes. Gartner says the Hype Cycle for Healthcare Providers “helps CIOs communicate with a range of stakeholders on future directions for health IT, analytics and medical innovation” and supports their decisions on identifying and prioritizing investments in this technology.1
AiRISTA Flow’s Unified Vision Solution has offered location-based tracking and reporting for more than 500 healthcare businesses, helping teams with enhanced hospital asset tracking, patient management, hygiene and compliance, medical temperature monitoring, and more. AiRISTA Flow, a leader in the healthcare space for over a decade as an experienced RTLS provider, has been listed as a Sample Vendor in the Healthcare Real-Time Location System category of the Gartner report.
AiRISTA Flow’s role in healthcare has rapidly become contributing to the industry’s future-focused shift to a real-time health system, which takes advantage of the latest technology to achieve efforts like integrated patient rooms, next-generation nurse calls, experiential wayfinding, end user experience monitoring, and medical device connectivity. RTLS technology is a significant part of creating a more connected healthcare ecosystem that better supports the path to value-based care.
Learn more about transformative technology impacting healthcare in the full Gartner report.
Fill out the form below to download a complimentary copy of Gartner’s Hype Cycle for Healthcare Providers, 2019.
- Gartner, “Hype Cycle for Healthcare Providers, 2019” Laura Craft, Mike Jones, July 29 2019.
- Gartner, “Magic Quadrant for Indoor Location Services, Global,” Tim Zimmerman, Annette Zimmermann, 28 January 2019.
About AiRISTA Flow
AiRISTA Flow develops and manufactures leading Identification & Track and Trace solutions using passive, active, and semi-active RFID, RTLS, GPS, and other technologies. AiRISTA Flow’s industry-based solutions are robust and comprehensive enabling increased visibility, security, and safety of mission-critical assets and personnel. Business process automation is enabled with full integration of AiRISTA Flow’s Business Rule Engine (BRE), GIS, and messaging platforms.
Gartner does not endorse any vendor, product, or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.